Subscribe
About us
Advertise with us

NeuroSens

Menu

Skip to content

Home
Neurology
Psychiatry

Topic: LGS

Clobazam in Lennox-Gastaut syndrome: phase III results

August 29, 2012

Browse by Topic

MS (281)
AD (81)
PD (77)
PREVIOUS CONGRESSES (37)
COVID-19 (36)
DEPRESSION (36)
MIGRAINE (26)

SCHIZOPHRENIA (25)
STROKE (22)
EPILEPSY (21)
ECTRIMS 2015 (13)
AAN 2015 (11)
ECTRIMS 2018 (10)
ECTRIMS 2014 (10)
ECTRIMS 2019 (10)
DEMENTIA (10)
ECTRIMS 2013 (9)
AAN 2013 (9)
AAN 2014 (9)
MS SEQUENCING (9)
PSYCHIATRY (8)
AAN 2019 (7)
ACTRIMS-ECTRIMS 2020 (7)
ECTRIMS 2017 (7)
CHARCOT 2013 (6)
ECTRIMS 2016 (6)
AAN 2021 (6)
ANXIETY (5)
BIPOLAR (5)
CCSVI (5)
EAN 2015 (4)
Library (4)
BPD (4)
NeuroSound (4)
AAN 2017 (4)
AAN 2020 (3)
PAIN (3)
AAN 2018 (3)
ENS 2013 (3)
EAN 2020 (2)
SPECIAL REPORT (2)
NEW DRUGS (2)
APA 2014 (2)
AAN 2016 (2)
SLEEP (2)
Dravet syndrome (1)
INSOMNIA (1)
WEST NILE (1)
EAN 2016 (1)
GUIDELINES (1)
LUMBAR PUNCTURE (1)
EAN 2019 (1)
TSC (1)
ADDICTION (1)
APA 2016 (1)
ALS (1)
SEIZURE (1)
EAN 2021 (1)
hATTR (1)
LGS (1)
CIDP (1)
CONCUSSION (1)
ECTRIMS 2020 (0)

View all Topics

Popular Posts

COVID vaccine interchangeability – what is the evidence? posted on June 8, 2021
COVID vaccination: is one dose better than nothing? posted on April 13, 2021
COVID-19 mortality in MS patients: a systematic review posted on June 1, 2021

Copyright 2021 Lind Publishing Inc All rights reserved. Developed by Integration New Media, INC. (INM)

Contact Us Terms and Conditions